DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0027066 | Myoclonus | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0018784 | Sensorineural Hearing Loss (disorder) | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0038273 | Stereotypic Movement Disorder | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C3714756 | Intellectual Disability | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0270790 | Quadriparesis | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0038220 | Status Epilepticus | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0520966 | Abnormal coordination | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C1857276 | Trichohepatoenteric Syndrome | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0028738 | Nystagmus | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C4317295 | Congenital disorder of glycosylation type 1s | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0025958 | Microcephaly | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0339143 | Thyroid associated opthalmopathies | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0013384 | Dyskinetic syndrome | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C3665347 | Visual Impairment | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0029124 | Optic Atrophy | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0007789 | Cerebral Palsy | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0494475 | Tonic - clonic seizures | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0037773 | Spastic Paraplegia, Hereditary | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0003864 | Arthritis | ST3GAL5 | 8869 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Q9UNP4 |
C0006142 | Malignant neoplasm of breast | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
C1956346 | Coronary Artery Disease | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
C0027651 | Neoplasms | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
C0010068 | Coronary heart disease | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
C0008311 | Cholangitis | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
C0003850 | Arteriosclerosis | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024